{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:07:09Z","timestamp":1784912829508,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Gallbladder cancer (GBC), the most common malignancy of the biliary tract, exhibits a high propensity for lymphatic system invasion. However, the mechanisms underlying lymphatic metastasis in GBC remain poorly understood. Here, we demonstrate that C\u2013C motif chemokine ligand 21 (CCL21) is significantly upregulated in GBC and positively correlates with lymphatic vessel density and lymph node metastasis. Both in vivo and in vitro experiments confirm that CCL21\/CCR7 axis promotes lymphangiogenesis and lymphatic metastasis in GBC. Mechanistically, CCL21\/CCR7 modulates Vascular Endothelial Growth Factor-D (VEGF-D) mRNA N6-Methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) modification in an AlkB homolog 5 (ALKBH5)-dependent manner, thereby regulating VEGF-D protein expression. Site-directed mutagenesis experiments reveal that m\n                    <jats:sup>6<\/jats:sup>\n                    A modification sites in the coding sequence (CDS) region of VEGF-D mRNA are critical for VEGF-D protein regulation. Collectively, our findings highlight that CCL21\/CCR7 regulates VEGF-D expression via m\n                    <jats:sup>6<\/jats:sup>\n                    A modification, driving lymphatic metastasis in GBC.\n                  <\/jats:p>","DOI":"10.1007\/s13577-026-01420-1","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:38:05Z","timestamp":1784911085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCL21\/CCR7 axis regulates VEGF-D m6A modification to drive lymphangiogenesis and lymphatic metastasis in gallbladder cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Zhenheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-3498","authenticated-orcid":false,"given":"Haijie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"1","key":"1420_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, et al. Gallbladder cancer [J]. Nat Rev Dis Primers. 2022;8(1):69.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"1420_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01979-z","volume":"23","author":"Z He","year":"2024","unstructured":"He Z, Zhong Y, Regmi P, et al. Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway. Mol Cancer. 2024;23(1):65.","journal-title":"Mol Cancer"},{"issue":"1","key":"1420_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41392-020-00324-2","volume":"5","author":"X Song","year":"2020","unstructured":"Song X, Hu Y, Li Y, et al. Overview of current targeted therapy in gallbladder cancer [J]. Signal Transduct Target Ther. 2020;5(1):230.","journal-title":"Signal Transduct Target Ther"},{"key":"1420_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.07.046","author":"D Piovani","year":"2024","unstructured":"Piovani D, Nikolopoulos GK, Aghemo A, et al. Environmental risk factors for gallbladder cancer: field-wide systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.07.046.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"16","key":"1420_CR5","doi-asserted-by":"publisher","first-page":"e2308531","DOI":"10.1002\/advs.202308531","volume":"11","author":"S Xu","year":"2024","unstructured":"Xu S, Yuan Z, Jiang C, et al. DNMT3A cooperates with YAP\/TAZ to drive gallbladder cancer metastasis [J]. Adv Sci. 2024;11(16):e2308531.","journal-title":"Adv Sci"},{"issue":"10251","key":"1420_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"key":"1420_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106234","volume":"98","author":"CF Feo","year":"2022","unstructured":"Feo CF, Ginesu GC, Fancellu A, et al. Current management of incidental gallbladder cancer: a review [J]. Int J Surg. 2022;98:106234.","journal-title":"Int J Surg"},{"issue":"4","key":"1420_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","volume":"19","author":"DJ Propper","year":"2022","unstructured":"Propper DJ, Balkwill FR. Harnessing cytokines and chemokines for cancer therapy [J]. Nat Rev Clin Oncol. 2022;19(4):237\u201353.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1420_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel TR, Lill JK, Altenburger LM. How chemokines organize the tumour microenvironment [J]. Nat Rev Cancer. 2024;24(1):28\u201350.","journal-title":"Nat Rev Cancer"},{"key":"1420_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041036","author":"B Rizeq","year":"2020","unstructured":"Rizeq B, Malki MI. The role of CCL21\/CCR7 chemokine axis in breast cancer progression. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12041036.","journal-title":"Cancers (Basel)"},{"issue":"19","key":"1420_CR11","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1021\/acs.nanolett.4c01267","volume":"24","author":"C Gao","year":"2024","unstructured":"Gao C, Zeng Y, Zhang L, et al. Sustained secretion of CCL21 via an implantable cell reservoir hydrogel enhances the systemic antitumor effect of radiotherapy [J]. Nano Lett. 2024;24(19):5894\u2013903.","journal-title":"Nano Lett"},{"issue":"2","key":"1420_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1053\/j.gastro.2020.04.037","volume":"159","author":"M Hirth","year":"2020","unstructured":"Hirth M, Gandla J, H\u00f6PER C, et al. CXCL10 and CCL21 promote migration of pancreatic cancer cells toward sensory neurons and neural remodeling in tumors in mice, associated with pain in patients [J]. Gastroenterology. 2020;159(2):665-81.e13.","journal-title":"Gastroenterology"},{"key":"1420_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12943-015-0306-4","volume":"14","author":"E Tutunea-Fatan","year":"2015","unstructured":"Tutunea-Fatan E, Majumder M, Xin X, et al. The role of CCL21\/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis [J]. Mol Cancer. 2015;14:35.","journal-title":"Mol Cancer"},{"issue":"9","key":"1420_CR14","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1002\/jcp.29525","volume":"235","author":"Y Chen","year":"2020","unstructured":"Chen Y, Shao Z, Jiang E, et al. CCL21\/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2\/STAT3 signaling pathway [J]. J Cell Physiol. 2020;235(9):5995\u20136009.","journal-title":"J Cell Physiol"},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13046-016-0318-y","volume":"35","author":"H Hong","year":"2016","unstructured":"Hong H, He C, Zhu S, et al. CCR7 mediates the TNF-\u03b1-induced lymphatic metastasis of gallbladder cancer through the \u201cERK1\/2 - AP-1\u201d and \u201cJNK - AP-1\u201d pathways [J]. J Exp Clin Cancer Res. 2016;35:51.","journal-title":"J Exp Clin Cancer Res"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-015-0268-9","volume":"34","author":"M Shi","year":"2015","unstructured":"Shi M, Chen D, Yang D, et al. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1 [J]. J Exp Clin Cancer Res. 2015;34:149.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1420_CR17","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.7150\/ijbs.67138","volume":"18","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhu L, Yao X, et al. Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21\/CCR7 axis [J]. Int J Biol Sci. 2022;18(4):1476\u201390.","journal-title":"Int J Biol Sci"},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1756-8722-5-63","volume":"5","author":"W Sun","year":"2012","unstructured":"Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy [J]. J Hematol Oncol. 2012;5:63.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1420_CR19","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3727\/000000007783980864","volume":"16","author":"W Naumnik","year":"2007","unstructured":"Naumnik W, Izycki T, Swidzi\u0144ska E, et al. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy [J]. Oncol Res. 2007;16(9):445\u201351.","journal-title":"Oncol Res"},{"key":"1420_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.818613","volume":"12","author":"A Ravaggi","year":"2022","unstructured":"Ravaggi A, Gambino A, Ferrari F, et al. VEGF-D serum level as a potential predictor of lymph node metastasis and prognosis in vulvar squamous cell carcinoma patients [J]. Front Oncol. 2022;12:818613.","journal-title":"Front Oncol"},{"issue":"5","key":"1420_CR21","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.ymthe.2021.01.031","volume":"29","author":"J Zhu","year":"2021","unstructured":"Zhu J, Luo Y, Zhao Y, et al. CircEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p\/TGF\u03b2R1\/VEGF-D signaling. Mol Ther. 2021;29(5):1838\u201352.","journal-title":"Mol Ther"},{"issue":"6","key":"1420_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1007\/s10120-020-01080-6","volume":"23","author":"T Pan","year":"2020","unstructured":"Pan T, Jin Z, Yu Z, et al. Cathepsin L promotes angiogenesis by regulating the CDP\/Cux\/VEGF-D pathway in human gastric cancer [J]. Gastric Cancer. 2020;23(6):974\u201387.","journal-title":"Gastric Cancer"},{"issue":"13","key":"1420_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1101\/gad.262766.115","volume":"29","author":"Y Yue","year":"2015","unstructured":"Yue Y, Liu J, He C. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation [J]. Genes Dev. 2015;29(13):1343\u201355.","journal-title":"Genes Dev"},{"issue":"1","key":"1420_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40164-025-00648-1","volume":"14","author":"YP Ding","year":"2025","unstructured":"Ding YP, Liu CC, Yu KD. RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond [J]. Exp Hematol Oncol. 2025;14(1):48.","journal-title":"Exp Hematol Oncol"},{"issue":"3","key":"1420_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.7150\/ijbs.104407","volume":"21","author":"ZH Liu","year":"2025","unstructured":"Liu ZH, Ma P, He Y, et al. The mechanism and latest progress of m6A methylation in the progression of pancreatic cancer [J]. Int J Biol Sci. 2025;21(3):1187\u2013201.","journal-title":"Int J Biol Sci"},{"issue":"15","key":"1420_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307122","volume":"11","author":"Y Sun","year":"2024","unstructured":"Sun Y, Chen D, Sun S, et al. RBMS1 coordinates with the m(6)A reader YTHDF1 to promote NSCLC metastasis through stimulating S100P translation [J]. Adv Sci (Weinh). 2024;11(15):e2307122.","journal-title":"Adv Sci (Weinh)"},{"issue":"10","key":"1420_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41419-024-07108-4","volume":"15","author":"YY Liu","year":"2024","unstructured":"Liu YY, Xia M, Chen ZB, et al. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1 [J]. Cell Death Dis. 2024;15(10):732.","journal-title":"Cell Death Dis"},{"issue":"13","key":"1420_CR28","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1158\/0008-5472.CAN-22-2449","volume":"83","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhou J, Li J, et al. N6-Methyladenosine promotes translation of VEGFA to accelerate angiogenesis in lung cancer. Cancer Res. 2023;83(13):2208\u201325.","journal-title":"Cancer Res"},{"issue":"6","key":"1420_CR29","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41419-024-06800-9","volume":"15","author":"Z Wu","year":"2024","unstructured":"Wu Z, Ke Q, Jiang L, et al. TGF-\u03b21 facilitates gallbladder carcinoma metastasis by regulating FOXA1 translation efficiency through m(6)A modification [J]. Cell Death Dis. 2024;15(6):422.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1420_CR30","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.20030361","volume":"198","author":"BK McColl","year":"2003","unstructured":"McColl BK, Baldwin ME, Roufail S, et al. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D [J]. J Exp Med. 2003;198(6):863\u20138.","journal-title":"J Exp Med"},{"key":"1420_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2259-4","volume":"16","author":"H Hong","year":"2016","unstructured":"Hong H, Jiang L, Lin Y, et al. TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1\/2\/AP-1\/VEGF-D pathway. BMC Cancer. 2016;16:240.","journal-title":"BMC Cancer"},{"key":"1420_CR32","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.2147\/OTT.S159026","volume":"11","author":"CZ Li","year":"2018","unstructured":"Li CZ, Jiang XJ, Lin B, et al. RIP1 regulates TNF-\u03b1-mediated lymphangiogenesis and lymphatic metastasis in gallbladder cancer by modulating the NF-\u03baB-VEGF-C pathway [J]. Onco Targets Ther. 2018;11:2875\u201390.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1420_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases [J]. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1420_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.immuni.2019.01.021","volume":"50","author":"J Liu","year":"2019","unstructured":"Liu J, Zhang X, Chen K, et al. CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1\u03b1-mediated glycolysis. Immunity. 2019;50(3):600-15.e15.","journal-title":"Immunity"},{"issue":"10","key":"1420_CR35","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1093\/nar\/gkw104","volume":"44","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Zeng P, Li YH, et al. SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res. 2016;44(10):e91.","journal-title":"Nucleic Acids Res"},{"key":"1420_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2024.11.001","author":"Y Luan","year":"2024","unstructured":"Luan Y, Jia R, Chai P, et al. m6A and beyond: RNA modifications shaping angiogenesis. Trends Mol Med. 2024. https:\/\/doi.org\/10.1016\/j.molmed.2024.11.001.","journal-title":"Trends Mol Med"},{"issue":"2","key":"1420_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1074\/jbc.M114.596551","volume":"290","author":"P L\u00f3PEZ-COTARELO","year":"2015","unstructured":"L\u00f3PEZ-COTARELO P, ESCRIBANO-D\u00edAZ C, GONZ\u00e1LEZ-BETHENCOURT IL, et al. A novel MEK-ERK-AMPK signaling axis controls chemokine receptor CCR7-dependent survival in human mature dendritic cells. J Biol Chem. 2015;290(2):827\u201340.","journal-title":"J Biol Chem"},{"issue":"2","key":"1420_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1189\/jlb.0811415","volume":"92","author":"T Kuwabara","year":"2012","unstructured":"Kuwabara T, Tanaka Y, Ishikawa F, et al. CCR7 ligands up-regulate IL-23 through PI3-kinase and NF-\u03ba B pathway in dendritic cells [J]. J Leukoc Biol. 2012;92(2):309\u201318.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1420_CR39","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41573-025-01280-8","volume":"25","author":"L Zhang","year":"2026","unstructured":"Zhang L, Wei J, Zou Z, et al. RNA modification systems as therapeutic targets [J]. Nat Rev Drug Discov. 2026;25(1):59\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"1420_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207619","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Grochans S, Gutowska I, et al. CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 ligands. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21207619.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1420_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188499","volume":"1875","author":"A Salem","year":"2021","unstructured":"Salem A, Alotaibi M, Mroueh R, et al. CCR7 as a therapeutic target in Cancer [J]. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188499.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"1420_CR42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41419-025-07372-y","volume":"16","author":"Z Wu","year":"2025","unstructured":"Wu Z, Peng Y, Chen W, et al. Lactylation-driven transcriptional activation of FBXO33 promotes gallbladder cancer metastasis by regulating p53 polyubiquitination. Cell Death Dis. 2025;16(1):144.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1420_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.canlet.2011.09.004","volume":"314","author":"W Lin","year":"2012","unstructured":"Lin W, Jiang L, Chen Y, et al. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer. Cancer Lett. 2012;314(2):127\u201336.","journal-title":"Cancer Lett"},{"key":"1420_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2025.101335","volume":"105","author":"J Tang","year":"2025","unstructured":"Tang J, Zhou C, Ye F, et al. RNA methylation homeostasis in ocular diseases: all eyes on Me. Prog Retin Eye Res. 2025;105:101335.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"1420_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Zhou X, Wang X. m(6)A binding protein YTHDF2 in cancer [J]. Exp Hematol Oncol. 2022;11(1):21.","journal-title":"Exp Hematol Oncol"},{"key":"1420_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116241","volume":"268","author":"Y Cai","year":"2024","unstructured":"Cai Y, Wang Y, Mao B, et al. Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer. Eur J Med Chem. 2024;268:116241.","journal-title":"Eur J Med Chem"},{"key":"1420_CR47","doi-asserted-by":"publisher","first-page":"1035871","DOI":"10.3389\/fonc.2022.1035871","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yang K, Bu J, et al. IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding [J]. Front Oncol. 2022;12:1035871.","journal-title":"Front Oncol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01420-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01420-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:38:06Z","timestamp":1784911086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01420-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01420-1","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"9 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human subjects is reviewed and approved by the Ethics Committee of Fujian Medical University Union Hospital. Patients\/participants provide written informed consent to participate in this study. The animal study has been approved by the Ethics Committee of the Medical Faculty of the Fujian Medical University.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"114"}}